B-type Natriuretic Peptide and Occult Pulmonary Hypertension in Premature Infants

Not Applicable

Recruiting

• Conditions: Pulmonary Hypertension/pulmonary vascular disease; Right Ventricular Dysfunction; Chronic Lung Disease; Premature Birth; Respiratory - Other respiratory disorders / diseases; Reproductive Health and Childbirth - Complications of newborn; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12614000674639
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-06-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Infants born at < 30 weeks gestation and cared for at Christchurch Women's Hospital NICU.

Exclusion Criteria

Known structural airway or lung anomalies, congenital anomalies of the pulmonary arteries or pulmonary veins, major systemic to pulmonary artery collateral vessels, congenital heart disease(except those with patent ductus arteriosus, patent foramen oval or atrial septal defect), severe liver disease and persistent pulmonary hypertension of the newborn (from birth).

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pulmonary hypertension (assessed by echocardiogram)[36 weeks post conceptual age]